Mark A White, DO | |
70 S Cleveland Ave, Westerville, OH 43081-1397 | |
(614) 890-6555 | |
(614) 823-7075 |
Full Name | Mark A White |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 30 Years |
Location | 70 S Cleveland Ave, Westerville, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649279837 | NPI | - | NPPES |
2285503 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 34-006320 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mount Carmel St Ann's | Westerville, OH | Hospital |
Fairfield Medical Center | Lancaster, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beacon Orthopaedics And Sports Medicine Ltd | 0345136412 | 438 |
News Archive
bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.
LaserBand LLC, a worldwide leader in patient identification wristbands, was announced as the sole source provider of proprietary patient identification (ID) wristbands and related products for Premier's ASCEND (Accelerated Supply Chain Endeavor) members.
Inclisiran lowers low-density lipoprotein (LDL; "bad") cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
New research by an international consortium, including a researcher from Lawrence Livermore National Laboratory, may help physicians better understand the chronological development of a brain aneurysm.
› Verified 4 days ago
Entity Name | Beacon Orthopaedics & Sports Medicine Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386670065 PECOS PAC ID: 0345136412 Enrollment ID: O20040225000690 |
News Archive
bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.
LaserBand LLC, a worldwide leader in patient identification wristbands, was announced as the sole source provider of proprietary patient identification (ID) wristbands and related products for Premier's ASCEND (Accelerated Supply Chain Endeavor) members.
Inclisiran lowers low-density lipoprotein (LDL; "bad") cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
New research by an international consortium, including a researcher from Lawrence Livermore National Laboratory, may help physicians better understand the chronological development of a brain aneurysm.
› Verified 4 days ago
Entity Name | Orthopedic & Neurological Consultants Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063507226 PECOS PAC ID: 6507827250 Enrollment ID: O20041026000093 |
News Archive
bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.
LaserBand LLC, a worldwide leader in patient identification wristbands, was announced as the sole source provider of proprietary patient identification (ID) wristbands and related products for Premier's ASCEND (Accelerated Supply Chain Endeavor) members.
Inclisiran lowers low-density lipoprotein (LDL; "bad") cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
New research by an international consortium, including a researcher from Lawrence Livermore National Laboratory, may help physicians better understand the chronological development of a brain aneurysm.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Mark A White, DO 70 S Cleveland Ave, Westerville, OH 43081-1397 Ph: (614) 890-6555 | Mark A White, DO 70 S Cleveland Ave, Westerville, OH 43081-1397 Ph: (614) 890-6555 |
News Archive
bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.
LaserBand LLC, a worldwide leader in patient identification wristbands, was announced as the sole source provider of proprietary patient identification (ID) wristbands and related products for Premier's ASCEND (Accelerated Supply Chain Endeavor) members.
Inclisiran lowers low-density lipoprotein (LDL; "bad") cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
New research by an international consortium, including a researcher from Lawrence Livermore National Laboratory, may help physicians better understand the chronological development of a brain aneurysm.
› Verified 4 days ago
Gunwant S Mallik, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 450 Alkyre Run, Suite 300, Westerville, OH 43082 Phone: 614-942-0132 Fax: 614-942-0139 | |
Bradford B Mullin, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 955 Eastwind Dr, Westerville, OH 43081 Phone: 614-268-9561 Fax: 614-268-7849 | |
William R Kemp, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 955 Eastwind Dr, Westerville, OH 43081 Phone: 614-268-9561 Fax: 614-268-7849 | |
Dr. William R Zerick, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 955 Eastwind Dr, Westerville, OH 43081 Phone: 614-268-0105 Fax: 614-268-5462 | |
Dr. Ying H Chen, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 70 S Cleveland Ave, Westerville, OH 43081 Phone: 614-890-6555 Fax: 614-839-3277 | |
Dr. Siddharth Uday Shetgeri, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 70 S Cleveland Ave, Westerville, OH 43081 Phone: 614-890-6555 |